ALMDT Median Technologies

Median Technologies : Bilan semestriel du contrat de liquidité

Regulatory News:

Au titre du contrat de liquidité portant sur les actions de la société Median Technologies (FR0011049824, ALMDT, éligible au plan PEA/PME, “Median” ou “la Société”) confié à TP ICAP (Europe), les moyens suivants figuraient au compte de liquidité à la date du 31/12/2024 :

  • 30 559 titres
  • 134 615,99 Euros en espèce.

Au cours du second semestre 2024, il a été négocié un total de :

ACHAT

253 462 titres

1 060 310,22 EUR

488 transactions

VENTE

259 038 titres

1 107 913,49 EUR

452 transactions

Il est rappelé que lors du bilan semestriel du 28/06/2024, les moyens suivants figuraient au compte de liquidité :

  • 36 135 titres
  • 89 040,54 Euros en espèce.

Il est rappelé que lors de la mise en place du nouveau contrat de liquidité au 04/05/2020, les moyens suivants ont été mis à disposition :

  • 4 404 titres
  • 173 829,64 Euros en espèce.

Le tableau journalier de transactions est en annexe de ce communiqué. TP ICAP (Europe) est autorisée et régulée par l’Autorité de Contrôle Prudentiel et de Résolution (ACPR) et l’Autorité des Marchés Financiers (AMF).

A propos de Median Technologies : Pionnière dans les logiciels dispositifs médicaux et services d’imagerie innovants, Median Technologies exploite les technologies de pointe d’Intelligence Artificielle pour augmenter la précision des diagnostics précoces et des traitements de nombreux cancers. Les offres de Median, iCRO pour l’analyse et la gestion des images médicales dans les essais cliniques en oncologie ​​et eyonis™, suite de logiciels dispositifs médicaux basés sur les technologies de l’IA, permettent aux sociétés biopharmaceutiques et aux cliniciens de faire progresser les soins aux patients et d'accélérer le développement de nouvelles thérapies. La société française, également présente aux Etats-Unis et en Chine, est cotée sur le marché Euronext Growth (ISIN : FR0011049824, MNEMO : ALMDT). Median Technologies est éligible au PEA-PME. Plus d’informations sur

ANNEXE : TABLEAU DES TRANSACTIONS JOURNALIERES

 

Achats

Vente

ALMDT FP

Nombre de Transactions

Nombre de titres

Capitaux en EUR

Nombre de Transactions

Nombre de titres

Capitaux en EUR

Total

488

253,462

1,060,310.22

452

259,038

1,107,913.49

20240701

1

1

2.63

4

2,641

7,066.23

20240702

3

1,761

4,616.69

1

1

2.69

20240703

2

921

2,376.25

2

137

364.41

20240704

2

225

585.04

1

1

2.64

20240705

1

1

2.63

4

2,601

6,991.43

20240708

1

1

2.74

3

2,041

5,637.54

20240709

4

3,211

8,695.59

2

851

2,399.79

20240710

4

3,111

8,176.26

1

1

2.66

20240711

4

2,941

7,455.60

1

1

2.60

20240712

4

2,851

6,828.26

1

1

2.46

20240715

6

3,991

9,172.78

1

1

2.38

20240716

3

1,651

3,587.80

2

1,351

3,053.20

20240717

5

2,718

5,887.23

1

1

2.27

20240718

5

3,921

8,068.52

1

1

2.12

20240719

0

0

0.00

0

0

0.00

20240722

1

1

3.92

11

11,951

47,209.12

20240723

5

2,961

11,187.20

2

1,141

4,564.00

20240724

5

2,961

10,448.10

2

1,191

4,406.70

20240725

6

3,131

10,512.67

4

3,241

11,563.87

20240726

1

1

3.78

11

10,591

41,863.78

20240729

4

2,831

10,842.40

3

1,325

5,307.68

20240730

4

3,371

12,929.70

7

5,611

23,218.70

20240731

1

1

3.99

4

2,431

9,752.39

20240801

1

1

4.17

5

2,891

12,357.17

20240802

5

3,651

14,961.52

4

1,621

6,943.12

20240805

1

1

3.87

1

1

3.87

20240806

1

1

3.88

4

2,181

8,681.28

20240807

1

1

4.30

11

6,531

28,582.50

20240808

4

2,716

12,448.80

12

5,431

26,734.78

20240809

2

1,011

5,136.05

5

1,821

9,639.95

20240812

2

1,001

5,265.32

16

5,751

33,324.96

20240813

6

4,224

24,533.55

7

1,708

10,417.39

20240814

4

2,201

12,904.98

1

1

5.98

20240815

3

1,651

9,730.99

1

1

5.99

20240816

2

861

5,062.73

4

1,471

8,871.93

20240819

5

2,605

15,755.32

14

5,531

35,700.52

20240820

3

1,631

10,366.97

4

1,201

7,967.77

20240821

3

1,306

9,559.21

12

4,140

30,016.33

20240822

7

4,275

30,024.79

4

974

7,160.41

20240823

5

2,441

16,951.00

1

1

7.00

20240826

6

3,074

20,942.44

1

1

6.84

20240827

1

1

6.88

6

2,431

17,173.28

20240828

4

1,621

11,327.95

1

1

7.15

20240829

6

2,991

19,610.61

3

1,351

9,486.81

20240830

16

9,490

58,990.20

5

2,251

16,035.10

20240902

9

4,211

23,162.05

1

1

5.75

20240903

3

921

4,939.82

8

5,481

31,361.62

20240904

3

1,131

6,201.52

1

1

5.52

20240905

1

1

5.58

8

5,821

34,091.78

20240906

11

7,151

38,820.73

1

1

5.83

20240909

10

5,221

24,982.39

1

1

4.99

20240910

5

2,011

8,942.53

5

3,981

18,732.93

20240911

5

2,361

9,855.00

5

3,761

16,782.60

20240912

9

5,241

22,775.18

5

3,381

15,873.78

20240913

1

1

4.31

7

5,431

23,964.51

20240916

6

3,401

14,818.50

1

1

4.50

20240917

6

3,231

13,064.07

1

1

4.12

20240918

2

253

1,017.11

5

3,931

16,559.07

20240919

4

2,167

8,619.59

3

1,210

4,995.25

20240920

4

2,121

8,351.80

11

8,141

34,611.60

20240923

6

3,661

15,911.00

3

1,531

7,019.60

20240924

3

1,321

5,851.08

2

951

4,336.48

20240925

3

1,331

5,788.85

2

981

4,394.85

20240926

6

3,441

14,580.93

1

1

4.33

20240927

3

1,134

4,547.62

3

1,861

7,751.22

20240930

5

2,231

9,204.39

4

1,801

7,743.39

20241001

5

2,581

10,858.89

1

1

4.29

20241002

1

1

4.07

2

1,141

4,700.87

20241003

4

2,001

7,919.07

1

1

4.07

20241004

1

1

3.98

7

6,531

27,162.38

20241007

4

2,241

9,406.88

1

1

4.28

20241008

4

1,357

5,519.96

2

1,031

4,330.12

20241009

4

2,121

8,606.32

1

1

4.12

20241010

5

2,561

10,119.70

1

1

4.10

20241011

5

2,441

9,157.85

2

1,191

4,621.05

20241014

4

1,901

6,839.22

3

1,274

4,716.30

20241015

4

1,851

6,659.10

2

1,271

4,702.70

20241016

4

1,791

6,515.08

4

2,298

8,659.96

20241017

1

1

3.78

5

4,411

16,993.18

20241018

1

1

3.93

5

3,841

15,564.53

20241021

5

2,961

11,700.31

3

1,751

7,258.51

20241022

4

2,161

8,811.73

1

1

4.13

20241023

5

2,601

10,381.72

1

1

4.12

20241024

3

1,411

5,522.36

1

1

3.96

20241025

5

2,291

8,869.34

1

1

3.94

20241028

4

1,661

6,307.89

4

3,711

14,677.29

20241029

4

1,781

6,905.90

1

1

3.90

20241030

4

1,691

6,388.00

1

1

3.80

20241031

1

1

3.80

4

3,281

12,692.20

20241101

1

1

3.88

5

4,241

16,931.68

20241104

4

2,011

8,119.69

1

1

4.09

20241105

3

1,227

4,878.35

1

1

3.99

20241106

5

2,371

9,289.41

4

2,501

10,162.01

20241107

1

1

3.93

10

8,971

37,225.93

20241108

6

3,691

15,492.18

1

1

4.38

20241111

1

1

4.11

4

2,491

10,383.51

20241112

6

3,711

15,228.80

1

1

4.20

20241113

1

1

4.06

5

3,701

15,441.46

20241114

4

2,311

9,700.70

1

1

4.30

20241115

2

611

2,505.20

2

1,041

4,393.00

20241118

4

2,271

9,078.72

1

1

4.12

20241119

5

2,781

10,704.69

1

1

3.89

20241120

4

1,991

7,600.89

1

1

3.89

20241121

9

5,081

17,810.55

1

1

3.75

20241122

6

2,611

8,707.40

2

259

901.24

20241125

1

1

3.46

5

4,991

17,713.06

20241126

9

5,031

16,311.88

1

1

3.48

20241127

2

471

1,431.99

5

5,001

16,061.09

20241128

4

2,091

6,309.89

5

4,581

14,861.44

20241129

1

1

3.27

6

5,681

18,900.97

20241202

6

4,091

12,893.20

1

1

3.20

20241203

4

2,521

7,425.76

3

2,061

6,317.56

20241204

1

1

3.08

5

3,534

11,085.74

20241205

4

2,621

8,119.00

1

1

3.20

20241206

1

1

3.10

4

3,441

11,062.70

20241209

1

1

3.20

5

3,721

12,461.60

20241210

1

1

3.50

2

971

3,393.65

20241211

5

3,591

12,266.27

1

1

3.47

20241212

4

2,541

8,633.25

1

1

3.45

20241213

1

1

3.40

11

8,621

31,589.20

20241216

6

4,261

16,040.14

8

5,301

21,614.54

20241217

6

4,531

16,693.59

1

1

3.79

20241218

5

2,987

10,590.42

3

1,701

6,268.78

20241219

4

2,601

9,186.94

1

1

3.54

20241220

4

2,451

8,523.72

3

1,901

6,853.52

20241223

1

1

3.68

8

6,901

26,053.68

20241224

1

1

3.61

3

1,551

5,746.61

20241225

0

0

0.00

0

0

0.00

20241226

0

0

0.00

0

0

0.00

20241227

1

1

3.69

2

511

1,962.09

20241230

4

2,961

10,948.52

1

1

3.72

20241231

2

761

2,830.98

2

931

3,537.78

 

FR
09/01/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Median Technologies

Maria Vara
  • Maria Vara

Median Technologies: Launch of EUR22m capital increase to unlock EIB f...

Median Technologies has launched a EUR22m capital increase via a public offering of shares with warrants (ABSA), priced at EUR1.66 (at ~18% discount to 20-day VWAP), with 78% of the deal already secured via existing and new investors. The raise aimed to i) meet the drawing conditions of the Tranche

Maria Vara
  • Maria Vara

Median Technologies: EIB loan signed, tied to equity raise and debt re...

Friday post-market, Median announced the final sign of the EIB loan agreement of EUR37.5m, which has been structured in three tranches (EUR19m, EUR8.5m, EUR10m) and with several key conditions being set to access the first one. These include i) a capital increase of at least EUR16m (including issua

Maria Vara
  • Maria Vara

Median Technologies: CE mark filing keep eyonis on track, US launch be...

Yesterday post-market, Median announced that it has submitted the Class IIb CE marking filing for eyonis LCS, just a month after the FDA 510(k) submission, precisely sticking to the company's timeline guidance. Our confidence in a positive outcome remains high, as both submissions are underpinned b

Maria Vara
  • Maria Vara

Median Technologies: eyonis LCS heads for FDA nod in Q3 2025

This morning, Median announced that it has submitted a 510(k) FDA filing for eyonis LCS, remaining on track with prior guidance and with a plausible clearance expected in Q3 2025. We are confident in a positive outcome, as the submission is underpinned by two pivotal studies—REALITY and RELIVE—whic

Maria Vara
  • Maria Vara

Median Technologies: FY24 wrap-up signals cost discipline, outlook rei...

Median Technologies released its audited FY 2024 results, which contain no surprises versus the unaudited data already disclosed in prior updates (see Q4 2024 and Q1 2025 notes). Revenue for the year came in at EUR22.9m (+3.3% YoY), fully driven by iCRO services, and the order backlog stood at EUR7

ResearchPool Subscriptions

Get the most out of your insights

Get in touch